Matching-adjusted Indirect Comparisons of Diroximel Fumarate, Ocrelizumab, and Interferon Beta-1a (P11-1.005)
To report matching-adjusted indirect comparisons (MAIC) of efficacy for diroximel fumarate (DRF) vs ocrelizumab (OCR) and DRF vs interferon beta-1a (IFN), disease-modifying therapies for relapsing multiple sclerosis.
Authors
- Yolanda Aladro (ORCID: https://orcid.org/0000-0001-9459-5452)
- Ivan Božin (ORCID: https://orcid.org/0009-0008-2205-4233)
- Changyu Shen (ORCID: https://orcid.org/0000-0002-4444-0943)
- Carrie M. Hersh (ORCID: https://orcid.org/0000-0002-5716-5645)
- James B. Lewin (ORCID: https://orcid.org/0000-0002-2352-9113)
- Zhaonan Sun (ORCID: https://orcid.org/0000-0001-5333-4387)
Institutions
- Biogen (United States) (US)
- Cleveland Clinic (US)
- Lou Ruvo Brain Institute (US)
- Hospital Universitario de Getafe (ES)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211854
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00